| Article | Date | Source |
|---|
| AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results | May 08, 2012 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals Announces Hiring of Kim Gaumer as Vice President, Regulatory Affairs and Quality Assurance | April 17, 2012 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals loses $6.4 million in Q4 | March 20, 2012 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results | March 20, 2012 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab(R) PCA System for the Treatment of Post-Operative Pain | March 07, 2012 | BioSpace - Breaking News |
| AcelRx Announces Initiation of Phase 3 Clinical Program for ARX-01, the Sufentanil NanoTab® PCA System for the Treatment of Post-Operative Pain | March 07, 2012 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences | February 21, 2012 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012 | January 31, 2012 | BioSpace - Breaking News |
| AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012 | January 31, 2012 | Biotech News - PR Newswire |
| Stratos Product Development Provides Design Expertise on AcelRx Pharmaceuticals' Advanced Drug Delivery System for Acute Pain Management | November 30, 2011 | Marketwire - Pharma and Biotech |
| AcelRx Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Health Care Conference | November 23, 2011 | Pharma News - PR Newswire |
| ACELRX PHARMACEUTICALS INC : AcelRx Pharmaceuticals Reports Third Quarter 2011 Financial Results | November 08, 2011 | Pharmaceutical - Moreover |
| AcelRx Pharmaceuticals Reports Third Quarter 2011 Financial Results | November 08, 2011 | Medical Pharma - PR Newswire |
| AcelRx Pharmaceuticals Appoints To Its Board of Directors | September 28, 2011 | Pharmaceutical - Moreover |
| AcelRx Pharmaceuticals Appoints Mark G. Edwards To Its Board of Directors | September 28, 2011 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals to Present at Two Healthcare Investor Conferences in the Second Half of September | September 15, 2011 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference | September 09, 2011 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals Q2 loss grows to $4.8 million | August 11, 2011 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Reports Second Quarter 2011 Financial Results | August 11, 2011 | Medical Pharma - PR Newswire |
| AcelRx Pharmaceuticals to Present at the Growth Conference | August 10, 2011 | Pharmaceutical - Moreover |
| AcelRx Pharmaceuticals to Present at the Canaccord Genuity Growth Conference | August 10, 2011 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals Secures $20 Million Loan Financing Agreement to Extend Operating Cash Runway Into 2013 | July 01, 2011 | BioSpace |
| AcelRx gets $20M loan for Phase III work | July 01, 2011 | FierceBiotech |
| AcelRx Pharmaceuticals sets up $20M loan deal | June 30, 2011 | Health News - BizJournals.com |
| AcelRx Secures $20 Million Loan Financing Agreement, Expected to Extend Its Operating Cash Runway Into 2013 | June 30, 2011 | Pharma News - PR Newswire |
| AcelRx wins $5.6M Army grant | May 31, 2011 | Health News - BizJournals.com |
| U.S. Army Awards AcelRx $5.6M for Phase II Trial of Sublingual Sufentanil Analgesic | May 31, 2011 | Inside Industry - Gen |
| AcelRx gets $5.6M Army grant | May 31, 2011 | Health News - BizJournals.com |
| AcelRx Announces $5.6 Million Department of Defense Grant to Develop ARX-04, a New Acute Pain Product Candidate | May 31, 2011 | Medical Pharma - PR Newswire |
| AcelRx Pharmaceuticals Reports First Quarter 2011 Financial Results | May 12, 2011 | Biotech News - PR Newswire |
| AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period | May 10, 2011 | Biotech News - PR Newswire |
| AcelRx Pharmaceuticals to Present at the Research Conference | May 06, 2011 | BioSpace - Breaking News |
| AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference | May 06, 2011 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals loses $3.5M in Q4, $14.3M in 2010 | March 24, 2011 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results | March 24, 2011 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference | March 07, 2011 | Pharma News - PR Newswire |
| AcelRx IPO raises $40 million | February 11, 2011 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Prices IPO at $5, Below the Original $12-$14 Range | February 11, 2011 | BioSpace |
| AcelRx falls short in $40M IPO | February 11, 2011 | FierceBiotech |
| AcelRx Gets $40M in IPO | February 11, 2011 | Xconomy Life Sciences |
| AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering | February 11, 2011 | Pharma News - PR Newswire |
| AcelRx Pharma Raises IPO Limit | February 10, 2011 | Pharmaceutical - Moreover |
| Pacira slashes IPO price while AcelRx braves a chilly market | February 03, 2011 | FierceBiotech |
| AcelRx Pharmaceuticals Prices IPO | January 24, 2011 | BioSpace |
| AcelRx Prices IPO | January 21, 2011 | Xconomy Life Sciences |
| AcelRx will try to sell investors on an $86M IPO | November 15, 2010 | FierceBiotech |
| Biotech AcelRx Pharmaceuticals Files For $86 Million IPO | November 15, 2010 | BioSpace - Breaking News |
| AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering | November 12, 2010 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals appoints new CFO | October 07, 2010 | Pharmaceutical - Moreover |
| AcelRx Pharmaceuticals Hires James Welch as Chief Financial Officer | October 04, 2010 | Medical Pharma - PR Newswire |
| AcelRx Pharmaceuticals Announces Completion of an End-of-Phase 2 Meeting With FDA for ARX-02, Sufentanil NanoTab??? Breakthrough Pain Management System | October 01, 2010 | BioSpace - Breaking News |
| AcelRx Announces Completion of an End-of-Phase 2 Meeting With FDA for ARX-02, Sufentanil NanoTab™ Breakthrough Pain Management System | October 01, 2010 | Pharma News - PR Newswire |
| Pain-relief focused AcelRx raises $8M | September 21, 2010 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain | May 25, 2010 | BioSpace - Breaking News |
| AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain | May 25, 2010 | Pharma News - PR Newswire |
| AcelRx Pharmaceuticals Sufentanil NanoTab PCA System (ARX-01) Phase 2 Results Featured in Poster Presentations at the 35th Annual Meeting of the American Society of Regional Anesthesia and Pain | April 20, 2010 | BioSpace - Breaking News |
| AcelRx Sufentanil NanoTab PCA System (ARX-01) Phase 2 Results Featured in Poster Presentations at the 35th Annual Meeting of the American Society of Regional Anesthesia and Pain to be held in Toronto on April 22-25th. | April 20, 2010 | Pharma News - PR Newswire |
| AcelRx names Richard King as president, CEO | April 07, 2010 | FierceBiotech |
| AcelRx Pharmaceuticals taps new CEO | April 06, 2010 | Health News - BizJournals.com |
| AcelRx Pharmaceuticals Names Chief Executive Officer | April 06, 2010 | BioSpace - Breaking News |
| AcelRx Pharmaceuticals names Richard King president, CEO | April 06, 2010 | Health News - BizJournals.com |
